Cargando…

Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria

BACKGROUND: Phenylketonuria (PKU) is a chronic inborn error of amino acid metabolism that requires lifelong follow-up and intervention, which may represent strains on Quality of Life (QoL). This observational study evaluated QoL in a cohort of PKU patients, using updated and detailed instruments. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Cazzorla, Chiara, Cegolon, Luca, Burlina, Alessandro P, Celato, Andrea, Massa, Pamela, Giordano, Laura, Polo, Giulia, Daniele, Aurora, Salvatore, Francesco, Burlina, Alberto B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265392/
https://www.ncbi.nlm.nih.gov/pubmed/25471331
http://dx.doi.org/10.1186/1471-2458-14-1243
_version_ 1782348879091466240
author Cazzorla, Chiara
Cegolon, Luca
Burlina, Alessandro P
Celato, Andrea
Massa, Pamela
Giordano, Laura
Polo, Giulia
Daniele, Aurora
Salvatore, Francesco
Burlina, Alberto B
author_facet Cazzorla, Chiara
Cegolon, Luca
Burlina, Alessandro P
Celato, Andrea
Massa, Pamela
Giordano, Laura
Polo, Giulia
Daniele, Aurora
Salvatore, Francesco
Burlina, Alberto B
author_sort Cazzorla, Chiara
collection PubMed
description BACKGROUND: Phenylketonuria (PKU) is a chronic inborn error of amino acid metabolism that requires lifelong follow-up and intervention, which may represent strains on Quality of Life (QoL). This observational study evaluated QoL in a cohort of PKU patients, using updated and detailed instruments. METHODS: 22 patients with mild PKU respondent to BH(4) and 21 patients with classical PKU treated with diet were recruited in this study. Adult patients completed WHOQOL questionnaire-100 (WHOQOL-100) and pediatric patients the Pediatric QoL inventory (PedsQL(TM)). Psychiatric and mood disorders were also evaluated using TAD or BDI and STAI-Y inventories. A multivariable linear regression model was fitted to investigate the predictors of QoL, including age, sex, treatment type, length of current treatment, educational level and employment status (only for adults) as covariates. Results were presented as regression coefficients with 95% confidence interval. RESULTS: Global QoL scores were within normal range both in patients with mild and classical disease but global QoL scores were significantly higher in patients with mild PKU under BH(4) treatment as compared to those affected by classical disease who were under diet regimen. Furthermore, QoL significantly increased in long treated PKU patients. Among adult patients, QoL scores were significantly lower in males, in patients with lower education and in those employed or unemployed as compared to students (baseline). CONCLUSIONS: Both diet and medical treatment based upon BH(4) seem to be associated with higher QoL in the long run. However, patients with mild PKU can rely on BH(4) to achieve a higher Phe tolerance and a better compliance to therapy due to diet relaxation/avoidance. Some specific categories of patients with a lower QoL should be investigated more in depth, engaging with those at risk of lower treatment compliance. The questionnaires employed in the present study seemed to be able to effectively detect criticalities in QoL assessment and represent an advance from previous inventories employed in the past.
format Online
Article
Text
id pubmed-4265392
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42653922014-12-15 Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria Cazzorla, Chiara Cegolon, Luca Burlina, Alessandro P Celato, Andrea Massa, Pamela Giordano, Laura Polo, Giulia Daniele, Aurora Salvatore, Francesco Burlina, Alberto B BMC Public Health Research Article BACKGROUND: Phenylketonuria (PKU) is a chronic inborn error of amino acid metabolism that requires lifelong follow-up and intervention, which may represent strains on Quality of Life (QoL). This observational study evaluated QoL in a cohort of PKU patients, using updated and detailed instruments. METHODS: 22 patients with mild PKU respondent to BH(4) and 21 patients with classical PKU treated with diet were recruited in this study. Adult patients completed WHOQOL questionnaire-100 (WHOQOL-100) and pediatric patients the Pediatric QoL inventory (PedsQL(TM)). Psychiatric and mood disorders were also evaluated using TAD or BDI and STAI-Y inventories. A multivariable linear regression model was fitted to investigate the predictors of QoL, including age, sex, treatment type, length of current treatment, educational level and employment status (only for adults) as covariates. Results were presented as regression coefficients with 95% confidence interval. RESULTS: Global QoL scores were within normal range both in patients with mild and classical disease but global QoL scores were significantly higher in patients with mild PKU under BH(4) treatment as compared to those affected by classical disease who were under diet regimen. Furthermore, QoL significantly increased in long treated PKU patients. Among adult patients, QoL scores were significantly lower in males, in patients with lower education and in those employed or unemployed as compared to students (baseline). CONCLUSIONS: Both diet and medical treatment based upon BH(4) seem to be associated with higher QoL in the long run. However, patients with mild PKU can rely on BH(4) to achieve a higher Phe tolerance and a better compliance to therapy due to diet relaxation/avoidance. Some specific categories of patients with a lower QoL should be investigated more in depth, engaging with those at risk of lower treatment compliance. The questionnaires employed in the present study seemed to be able to effectively detect criticalities in QoL assessment and represent an advance from previous inventories employed in the past. BioMed Central 2014-12-04 /pmc/articles/PMC4265392/ /pubmed/25471331 http://dx.doi.org/10.1186/1471-2458-14-1243 Text en © Cazzorla et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Cazzorla, Chiara
Cegolon, Luca
Burlina, Alessandro P
Celato, Andrea
Massa, Pamela
Giordano, Laura
Polo, Giulia
Daniele, Aurora
Salvatore, Francesco
Burlina, Alberto B
Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria
title Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria
title_full Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria
title_fullStr Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria
title_full_unstemmed Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria
title_short Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria
title_sort quality of life (qol) assessment in a cohort of patients with phenylketonuria
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265392/
https://www.ncbi.nlm.nih.gov/pubmed/25471331
http://dx.doi.org/10.1186/1471-2458-14-1243
work_keys_str_mv AT cazzorlachiara qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria
AT cegolonluca qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria
AT burlinaalessandrop qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria
AT celatoandrea qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria
AT massapamela qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria
AT giordanolaura qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria
AT pologiulia qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria
AT danieleaurora qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria
AT salvatorefrancesco qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria
AT burlinaalbertob qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria